Azenta director granted 5,663 unrestricted shares

Azenta, Inc. director Tina S. Nova received an equity grant of 5,663 common shares under the company’s 2020 Equity Incentive Plan.

Rhea-AI Filing Summary

Azenta, Inc. director Tina S. Nova received an equity grant of 5,663 common shares under the company’s 2020 Equity Incentive Plan. The grant consisted of unrestricted shares, and no amount was paid upon grant. Following this award, she beneficially owns 15,772 Azenta common shares directly.

Insights

Corporate governance and compensation analyst

Routine director equity grant modestly increases alignment with shareholders.

Azenta, Inc. granted director Tina S. Nova 5,663 unrestricted common shares under its 2020 Equity Incentive Plan. Because no cash was paid for the grant, this is standard equity-based compensation rather than an open-market share purchase.

After the grant, Nova holds 15,772 common shares directly. This filing mainly documents ongoing board compensation practices and a modest increase in her ownership stake, without indicating any change in company strategy or financial outlook.

Insider Trade Summary

Grant/Award: 5,663 shares

Grant/Award 1 txn

Insider Nova Tina Susan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common	5,663	$27.85	$158K

Holdings After Transaction: Common — 15,772 shares (Direct)

Footnotes (1)

1. F1. Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Azenta (AZTA) director Tina S. Nova report in this Form 4 filing?

Tina S. Nova reported receiving 5,663 Azenta common shares as an equity grant. The shares were awarded under Azenta’s 2020 Equity Incentive Plan as unrestricted stock, increasing her directly held position to 15,772 shares after the transaction was recorded.

How many Azenta (AZTA) shares does Tina S. Nova own after this reported grant?

After the reported grant, Tina S. Nova beneficially owns 15,772 Azenta common shares directly. This total includes the 5,663 unrestricted shares granted to her on February 6, 2026, under the company’s 2020 Equity Incentive Plan, as disclosed in the Form 4 filing.

Was cash paid for the Azenta (AZTA) shares granted to Tina S. Nova?

No cash was paid for the shares. The Form 4 footnote explains that the 5,663 Azenta common shares were granted as unrestricted stock under the 2020 Equity Incentive Plan, and explicitly states that no amount was paid upon grant of the shares.

What type of transaction is disclosed in Tina S. Nova’s Azenta (AZTA) Form 4?

The Form 4 discloses an "A" code transaction, meaning an acquisition of securities, specifically an equity grant. Nova received 5,663 unrestricted Azenta common shares under the 2020 Equity Incentive Plan, rather than buying them on the open market for cash.

What is Tina S. Nova’s role at Azenta (AZTA) as shown in this filing?

The filing identifies Tina S. Nova as a director of Azenta, Inc. She is not reported as an officer or a 10% owner in this document. The equity grant of 5,663 unrestricted shares represents part of her compensation for serving on the company’s board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 06:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nova Tina Susan

(Last) (First) (Middle)

C/O AZENTA, INC.

200 SUMMIT DRIVE, 6TH FLOOR

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Azenta, Inc. [ AZTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	02/06/2026		A		5,663(1)	A	$27.85	15,772	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

	/s/Ephraim Starr, Attorney-in-fact for Tina S. Nova	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.